1E1ciJi
1E1ciJi
1E1ciJi
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
T. Warner Hudson, M.D.<br />
UCLA Health System and Campus<br />
Medical Director<br />
T. Warner Hudson M.D., FACOEM FAAFP<br />
is Medical Director of Occupational and<br />
Employee Health for UCLA Health System and Campus,<br />
with about 50,000 employees. He has been working to<br />
improve employee population health since the 1980s,<br />
serving in leadership roles as Corporate Medical Director,<br />
VP of Medical Affairs, VEBA Trustee, Director of Health,<br />
Safety and Environment, Medical Director of Workers<br />
Compensation, Medical Director for on - site clinics and more<br />
for multinational employers and health systems including<br />
DST, Cisco Systems, and Sutter Health to mention a few<br />
prior to UCLA. He was President of ACOEM in 2011-2012,<br />
and is board certified and a fellow in both Family Medicine<br />
and Occupational Medicine. He has numerous scientific<br />
publications, was a faculty member at UC Davis for over<br />
25 years before coming to UCLA, and has worked with the<br />
University of California office of the President on a variety of<br />
initiatives across all campuses including moving all of UC to<br />
tobacco free campuses in 2014, and on a focused wellness<br />
initiative for injured workers called WorkStrong, as well as<br />
many UCLA specific initiatives and pilot programs.<br />
Antonio Iglesias, Pharm.D.<br />
Pfizer, Inc.<br />
Regional Medical Director<br />
Antonio J. Iglesias is a Medical Director in the<br />
field-based Health Economics & Outcomes<br />
Research Team whose mission is to help customers discover<br />
the real-world value, both human and economic, of Pfizer<br />
products by being a first in class, trusted, customer facing,<br />
medical partner who meets the real-world needs of our<br />
customer by generating, interpreting and communicating<br />
health outcomes and pharmacoeconomic information.<br />
Tony started his Pharmacy career as a Pediatrics Clinical<br />
Pharmacist at Jackson Health System in Miami and<br />
progressed to Coordinator of Academic Programs prior<br />
to joining Pfizer in November 2003. At Pfizer, he started<br />
as a member of the Primary Care Business Unit fieldbased<br />
Medical Outcomes Specialists supporting South<br />
Florida and in June 2012 he joined the IORS team covering<br />
the US Southeast. As part of the field-based medical<br />
organization, Tony has supported key Pfizer therapeutic<br />
areas collaborating with customers to develop innovative<br />
and targeted solutions to advance patient care quality. He<br />
has supported pharmacoeconomics and outcomes projects<br />
to identify knowledge gaps and help inform formulary<br />
decision-making across the product cycle. Tony has over<br />
24 years of health-related experience in various sectors<br />
including pharmaceutical industry, academia, managed care<br />
organizations, and government. He received a BS degree in<br />
Chemical Engineering and a Doctor of Pharmacy degree from<br />
the University of Florida, and completed a Pharmacy Practice<br />
Residency in Pediatrics at Jackson Memorial Health System.<br />
He lives in Miami, Florida.<br />
Fikry Isaac, M.D.<br />
Johnson & Johnson<br />
Vice President of Global Health Services<br />
Dr. Isaac is Vice President of Global<br />
Health Services for Johnson & Johnson,<br />
Inc., in New Brunswick, New Jersey. In this role, Dr. Isaac<br />
directs the development of health and wellness strategies,<br />
policies, guidelines, and services worldwide (Occupational<br />
Medicine, Employee Assistance Program and Wellness).<br />
Dr. Isaac is also the Chief Medical Officer for Johnson &<br />
Johnson’s Health & Wellness Solutions – a company offering<br />
comprehensive wellness solutions for employers, health<br />
plans, and other organizations. Dr. Isaac is a pioneer in the<br />
field of workplace health promotion and global health, and<br />
has introduced innovative approaches to improve the health<br />
and well-being of populations. He is a published author<br />
in this field and continues to research population health<br />
interventions, using rigorous scientific methods, to ensure<br />
that these interventions deliver meaningful outcomes. His<br />
broad view spans the fields of clinical medicine, behavior<br />
change technologies, and economic analyses. Dr. Isaac is an<br />
outspoken champion of prevention and health promotion and<br />
has achieved remarkable success within Johnson & Johnson—<br />
gaining senior management support and funding for health<br />
improvement initiatives for all Johnson & Johnson employees<br />
worldwide.<br />
Kimberly Jinnett, Ph.D.<br />
Integrated Benefits Institute<br />
Executive Vice President<br />
Dr. Kimberly Jinnett is Executive Vice<br />
President at the Integrated Benefits Institute.<br />
Jinnett joined IBI in June 2005 and is responsible for<br />
overseeing IBI’s research. Previously, she was a health policy<br />
researcher at RAND and at the Department of Veterans<br />
Affairs. Most recently, Dr. Jinnett served as Senior Evaluation<br />
Officer, developing and managing research investments for<br />
a major national foundation across a variety of substantive<br />
areas including leadership, organizational behavior, use<br />
of incentives and social change. She has served in senior<br />
management positions in a variety of nonprofit organizations,<br />
county and federal agencies. Jinnett received her bachelor’s<br />
degree in psychobiology and master’s degree in public health<br />
from the University of California, Los Angeles. She received<br />
her Ph.D. in sociology and health services organization and<br />
policy from the University of Michigan, Ann Arbor.<br />
26 2015 IBI Annual Forum Speaker Biographies
Change language